Healius Ltd (PHCRF)
2.13
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 1.547B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 0.00% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 1.155 |
Price to Book Value | 2.161 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 1.538 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 43.42% |
Profile
Healius is Australia’s second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging. |
URL | https://www.healius.com.au |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Providers & Services |
Equity Style | Small Cap/Value |
Next Earnings Release | Aug. 29, 2024 (est.) |
Last Earnings Release | Feb. 26, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Mar. 16, 2018 |
Ratings
Profile
Healius is Australia’s second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging. |
URL | https://www.healius.com.au |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Providers & Services |
Equity Style | Small Cap/Value |
Next Earnings Release | Aug. 29, 2024 (est.) |
Last Earnings Release | Feb. 26, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Mar. 16, 2018 |